Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus–Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practi
by from Morbidity and Mortality Weekly Report (MMWR) on (#6ZMRB)
This report describes CDC's recommendation for use of clesrovimab for prevention of severe respiratory syncytial virus (RSV) in infants.